Nitric oxide-donating genistein prodrug: Design, synthesis, and bioactivity on MC3T3-E1 cells

Journal of Pharmacological Sciences

Volumn 104, Issue 1, 2007, Pages 82-89

  Wang, Jiepin ^a   Shang, Fujun ^b   Jiang, Ru ^a   Liu, Li ^a   Wang, Siwang ^a   Hou, Jin ^a   Huan, Menglei ^a   Mei, Qibing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bioactivity; MC3T3 E1 cell; Nitric oxide (NO) releasing prodrug; Postmenopausal osteoporosis; Synthesis

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; GENISTEIN; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVITY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MELTING POINT; MINERALIZATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSTEOBLAST; STAINING;

EID: 34249110626     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0061549     Document Type: Article

References (25)

1. Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States: Number, costs, and potential effects of postmenopansal estrogen. Clin Orthop. 1990;252:163-166.
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
3. Kanno S, Hirano S, Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology. 2004;196:137-145.
4. Ishimi Y, Arai N, Wang X, Wu J, Umegaki K, Miyaura C, et al. Difference in effective dosage of genistein on bone and uterus in ovariectomized mice.Biochem Biophys Res Commun. 2000;274:697-701.
5. Chen X, Garner SC, Quarles LD, Anderson JJ. Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. J Nutr Biochem. 2003;14:342-349.
6. Pie JE, Park JH, Park YH, Ryu YM, Kim KN, Suh SW, et al. Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J Nutr Biochem. 2006;17:157-164.
7. Kuwabara M, Kakinuma Y, Ando M, Katare RG, Yamasaki F, Doi Y, et al. Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis. J Physiol Sci. 2006;56:95-101.
8. Nakamura K, Habano W, Kojo T, Komagiri Y, Kubota T, Kubokawa M. Involvement of endogenous nitric oxide in the regulation of K(+) channel activity in cultured human proximal tubule cells. J Physiol Sci. 2006;56:407-413.
9. Van't Hof RJ, Ralston SH Nitric oxide and bone. Immunology. 2001;103:255-261.
10. Hukkanen M, Platts LA, Lawes T, Girgis SI, Konttinen YT, Goodship AE, et al. Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone. 2003;32:142-149.
11. Koyama A, Otsuka E, Inoue A, Hirose S, Haqiwara H. Nitric oxide accelerates the ascorbic acid-induced osteoblastic differentiation of mouse stromal ST2 cells by stimulating the production of prostaglandin E(2). Eur J Pharmacol. 2000;391:225-231.
12. Wimalawansa SJ. Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study. J Bone Miner Res. 2000;15:2240-2244.
13. Kasten TP, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko TP, et al. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci U S A. 1994;91:3569-3573.
14. Mancini L, Moradi-Bidhendi N, Becherini L, Martineti V, MacIntyre I. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent. Biochem Biophys Res Commun. 2000;274:477-481.
15. Hou J, Xiong XY, Mi M, Wang JP, Liu L, Mei QB. Effects of xy9002 on the proliferation and differentiation of MC3T3-E1 cells. Chin Pharmacol Bull. 2006;22:529-532.
16. Muir CP, Adams MA, Graham CH. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells. Breast Cancer Res Treat. 2006;96:169-176.
17. Sado T, Saito S, Morikawa H. Study on the mechanism of the bone formation process by 17 beta-estradiol during rat bone marrow stromal cell culture. J Obstet Gynaecol Res. 2003;29:361.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
19. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252-4263.
20. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138:863-870.
21. Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat KP, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem. 2001;49:2472-2479.
22. Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, et al. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol. 2006;71:1459-1469.
23. Latonnelle K, Fostier A, Le Menn F, Bennetau-Pelissero C. Binding affinities of hepatic nuclear estrogen receptors for phytoestrogens in rainbow trout (Oncorhynchus mykiss) and Siberian sturgeon (Acipenser baeri). Gen Com Endocrinol. 2002;129:69-79.
24. O'Shaughnessy MC, Polak JM, Afzal F, Hukkanen MV, Huang P, MacIntyre I, et al. Nitric oxide mediates 17β-estradiol-stimulated human and rodent osteoblast proliferation and differentiation. Biochem Biophy Res Commun. 2000;277:604-610.
25. Armour KE, Ralston SH. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology. 1998;139:799-802.